Selamectin EP Impuity B CAS#: 165108-09-8
Identification
| 英文名 | Selamectin EP Impuity B |
| 分子结构 | ![]() |
| CAS编号 | 165108-09-8 |
| EINECS Number | |
| MDL Number | |
| Beilstein Registry Number | |
| 别名 | (2aE,2′S,4E,5′S,6S,6′R,7S,8E,11R,15S,17aR,20Z,20aR,20bS)-6′-Cyclohexyl-7-[(2,6-dideoxy-3-O-methyl-alpha-L-arabino-hexopyranosyl)oxy]-20b-hydroxy-20-(hydroxyimino)-5′,6,8,19-tetramethyl-5′,6,6′,7,10,11,14,15,17a,20,20a,20b-dodecahydrospiro[2H,17H-11,15-methanofuro[4,3,2-pq][2,6]benzodioxacyclooctadecine-13,2′-pyran]-17-one ((5Z,25R)-25-cyclohexyl-4′-O-de(2,6-dideoxy-3-O-methyl-alpha-L-arabino-hexopyranosyl)-5-demethoxy-25-de(1-methylpropyl)-5-(hydroxyimino)avermectin A1a) |
| 分子式 | C43H61NO11 |
| 分子量 | 768.0 |
| InChI | |
| InChI Key | |
| Canonical SMILES | CC1=C[C@@]2([H])C(O[C@@]3([H])C[C@](C/C=C(C)/[C@](O[C@@H]4O[C@@H](C)[C@H](O)[C@@H](OC)C4)([H])[C@@]([H])(C)/C=C/C=C5[C@]2(O)[C@@](OC/5)([H])/C1=NO)([H])O[C@]6(O[C@@](C7CCCCC7)([H])[C@@]([H])(C)C=C6)C3)=O |
Physical Data
| Appearance | No data available |
| Solubility | No data available |
| Flash Point | No data available |
| Refractive index | No data available |
| Sensitivity | No data available |
| Melting Point | No data available |
Spectra
| No data available |
Route of Synthesis (ROS)
| No data available |
Safety and Hazards
| No data available |
Other Data
| HS Code | 382290 |
| Storage | At room temperature and away from light |
| Related Chemicals |
| Use Pattern |
| Selamectin EP Impuity B is chemically (2aE,2′S,4E,5′S,6S,6′R,7S,8E,11R,15S,17aR,20Z,20aR,20bS)-6′-Cyclohexyl-7-[(2,6-dideoxy-3-O-methyl-alpha-L-arabino-hexopyranosyl)oxy]-20b-hydroxy-20-(hydroxyimino)-5′,6,8,19-tetramethyl-5′,6,6′,7,10,11,14,15,17a,20,20a,20b-dodecahydrospiro[2H,17H-11,15-methanofuro[4,3,2-pq][2,6]benzodioxacyclooctadecine-13,2′-pyran]-17-one ((5Z,25R)-25-cyclohexyl-4′-O-de(2,6-dideoxy-3-O-methyl-alpha-L-arabino-hexopyranosyl)-5-demethoxy-25-de(1-methylpropyl)-5-(hydroxyimino)avermectin A1a). Selamectin EP Impuity B is supplied with detailed characterization data compliant with regulatory guideline. Selamectin EP Impuity B can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Selamectin. The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. ChemWhat products are for analytical purpose only and not for human use. |